Analyst Ratings for Candel Therapeutics Inc. (CADL)
CADL Rating Summary
CADL Price Target Summary
- Highest: $23.00 (H.C. Wainwright)
- Lowest: $9.00 (BofA Securities)
- Average: $16.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.50 (+62.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$16.50 (+62.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Stifel | Stephen Willey | New Coverage | Buy (N/A) |
22.00 (N/A) |
9.89 (10.18) |
2.93% | Details |
| 4/20/2026 | Cantor Fitzgerald | Imogen Mansfield | New Coverage | Overweight (N/A) |
N/A (N/A) |
6.37 (10.18) |
59.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
